Skip to main content
. 2023 Jan 18;20:4. doi: 10.1186/s12014-023-09392-2

Table 1.

Baseline characteristics of patients in the validation group

Characteristics Total (n = 27) CRRT (n = 17) non-CRRT (n = 10) P value
Body weight, kg 17.75 (12.38, 32.40) 19 (15, 28) 15 (8.58, 45) 0.372
Age, month 64 (24, 114) 65 (33.5, 113.5) 44.5 (4.75, 117.25) 0.436
Male, n (%) 13 (48%) 8 (47%) 5 (50%)  > 0.999
PRISM III 2.50 (0.75, 4.50) 1.5 (0.25, 4) 4 (1.5, 6) 0.296
CRP, mg/L 100 (54, 160) 89 (45.5,154) 137 (65.75, 160) 0.420
WBC, × 109 /L 8.25 (3.99,13.70) 8.25 (4.64,14.07) 7.58 (3.03,14.45) 0.673
PCT, ng/mL 1.06 (0.22, 12.67) 0.52 (0.2, 2.54) 10.48 (0.51, 42.93) 0.088
ALT, U/L 34 (25, 57.50) 51 (24, 60) 30.5 (26, 74.75) 0.739
TBIL, μmol/L 20.31 (10.13,27.41) 25.08 (9.65,31.95) 12.80 (9.78,24.48) 0.108
γ-GT, U/L 20.50 (11.25, 96.5) 17 (11, 82) 63 (15.5, 135) 0.200
Fib, g/L 2.97 (2.06, 4.67) 2.73 (1.89, 4.19) 3.81 (2.74, 7.10) 0.092
APTT, s 39.85 (35.53, 143.15) 80.7 (38.6, 155.6) 36.1 (28.98, 38.25) 0.015a
INR 1.39 (1.21, 1.55) 1.37 (1.20, 1.76) 1.40 (1.26, 147) 0.916
PT, s 15 (13.53, 17.10) 15.35 (13.75, 19.05) 14.8 (11.95, 16.15) 0.444
PLT, × 109 /L 161 (77,274) 161 (83.5,255.5) 171.5 (43.5,327.5) 0.725
Cr, μmol/L 29 (25.5, 52.6) 29 (25, 35) 27.8 (25.28, 62.43) 0.598
BUN, mmol/L 4.10 (2.75,8.90) 3.90 (2.10,5.20) 7.07 (3.75,11.00) 0.063
Alb, g/L 32.31 (29.70,38.25) 31.58(26.60,35.62) 34.30(31.25,40.175) 0.120
Lac, mmol/L 2.15 (1.10,2.80) 2.5 (1.45, 3.05) 0.9 (0.7, 2.2) 0.061

PRISM III pediatric risk of mortality III, CRP c-reactive protein, WBC white blood cell, PCT procalcitonin, ALT alanine aminotransferase, TBIL bilirubin, γ-GT γ-glutamyl transpeptidase, Fib fibrinogen, APTT activated partial thromboplastin time, INR international normalized ratio, PT prothrombin time, PLT platelet, Cr creatinine, BUN blood urea nitrogen, Alb albumin, Lac lactate

aP < 0.05